Compare · EVH vs RTO
EVH vs RTO
Side-by-side comparison of Evolent Health Inc (EVH) and Rentokil Initial plc (RTO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EVH and RTO operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- RTO is the larger of the two at $15.33B, about 23.5x EVH ($653.5M).
- Over the past year, EVH is down 40.4% and RTO is up 27.8% - RTO leads by 68.3 points.
- EVH has been more active in the news (6 items in the past 4 weeks vs 3 for RTO).
- EVH has more recent analyst coverage (20 ratings vs 13 for RTO).
- Company
- Evolent Health Inc
- Rentokil Initial plc
- Price
- $5.81+2.47%
- $30.39-0.02%
- Market cap
- $653.5M
- $15.33B
- 1M return
- +23.35%
- +0.25%
- 1Y return
- -40.44%
- +27.84%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- 2022
- News (4w)
- 6
- 3
- Recent ratings
- 20
- 13
Evolent Health Inc
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Latest EVH
- Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
- Chief Executive Officer Blackley Seth was granted 446,102 shares and covered exercise/tax liability with 10,297 shares, increasing direct ownership by 52% to 1,272,767 units (SEC Form 4) (tax liability)
- General Counsel Weinberg Jonathan was granted 43,055 shares and covered exercise/tax liability with 2,650 shares, increasing direct ownership by 17% to 284,917 units (SEC Form 4) to satisfy tax liability
- PRESIDENT Mccarthy Daniel Joseph was granted 302,585 shares and covered exercise/tax liability with 4,582 shares, increasing direct ownership by 70% to 721,025 units (SEC Form 4) to cover withholding tax
- Chief Accounting Officer Shams Aammaad was granted 28,790 shares, increasing direct ownership by 43% to 95,637 units (SEC Form 4)
- Evolent Health downgraded by Truist with a new price target
- SEC Form S-8 filed by Evolent Health Inc
- Director Ajayi Toyin was granted 41,096 shares, increasing direct ownership by 121% to 75,170 units (SEC Form 4)
- Director Glass Russell Monroe was granted 41,096 shares, increasing direct ownership by 113% to 77,347 units (SEC Form 4)
- Director Grua Peter J was granted 41,096 shares, increasing direct ownership by 187% to 63,075 units (SEC Form 4)
Latest RTO
- SEC Form 6-K filed by Rentokil Initial plc
- Rentokil Initial plc upgraded by Goldman
- The Round of 32 Pest Scouting Report: Which Host Cities Face a "Double Threat"?
- Rentokil Terminix Launches Multi-Brand Digital Advancements to Enhance Customer Experience
- SEC Form SD filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- Terminix Debuts New Podcast to Help Businesses Mitigate Operational Risk
- SEC Form 6-K filed by Rentokil Initial plc